Clinical Trials in Cleveland

Showing 3961-3980 of 19,775 trials

Open Label Extension of Efgartigimod in Adults With Post-COVID-19 POTS

NCT05918978

The OLE study aims to investigate the safety, efficacy, pharmacodynamics (PD), pharmacokinetics (PK), and immunogenicity of efgartigimod in participants with post-COVID-19 postural orthostatic.

Post-COVID Postural Orthostatic Tachycardia Syndrome Postural Orthostatic Tachycardia Syndrome

argenx33 participantsStarted Jun 2023

La Jolla, California, United States • Palo Alto, California, United States • Glenview, Illinois, United States +6 more locations

COMPLETEDPhase 1< 1 mile

Vincristine Sulfate Liposome Injection (Marqibo®) in Combination With UK ALL R3 Induction Chemotherapy

NCT02879643

This is a pilot study utilizing Marqibo® (vincristine sulfate liposome injection) combined with dexamethasone, mitoxantrone and asparaginase (UK ALL R3) for relapsed acute lymphoblastic leukemia (ALL).

ALL, ChildhoodLymphoblastic Leukemia, Acute, ChildhoodLymphoblastic Leukemia, Acute

Therapeutic Advances in Childhood Leukemia Consortium29 participantsStarted Jan 2017

Los Angeles, California, United States • Orange, California, United States • San Francisco, California, United States +32 more locations

Open Label Extension of Efgartigimod in Adults With Post-COVID-19 POTS

Vincristine Sulfate Liposome Injection (Marqibo®) in Combination With UK ALL R3 Induction Chemotherapy

Find Trials by Condition in Cleveland

Corneal Elastography and Patient Specific Modeling

Medtronic Transcatheter Aortic Valve Replacement (TAVR) Low Risk Bicuspid Study

To Evaluate Efficacy and Safety of Serplulimab + Chemotherapy (Carboplatin- Etoposide) in US Patients With ES-SCLC

Phase 1b Study of OP-1250 (Palazestrant) in Combination With Ribociclib, Alpelisib, Everolimus, or Atirmociclib in ER+, HER2- Breast Cancer

A Study of Olezarsen Administered Subcutaneously to Participants With Severe Hypertriglyceridemia

Extension Study to Evaluate Safety and Efficacy of CTP-543 in Adults With Alopecia Areata

Intrahepatic Delivery of SD-101 by Pressure-Enabled Regional Immuno-oncology (PERIO), With Checkpoint Blockade in Adults With Metastatic Uveal Melanoma

A Study of Sotorasib (AMG 510) in Participants With Stage IV NSCLC Whose Tumors Harbor a KRAS p.G12C Mutation in Need of First-line Treatment

Safety and Proof-of-Concept (POC) Study With AMT-130 in Adults With Early Manifest Huntington's Disease

Study of Chemotherapy With Pembrolizumab (MK-3475) Followed by Maintenance With Olaparib (MK-7339) for the First-Line Treatment of Women With BRCA Non-mutated Advanced Epithelial Ovarian Cancer (EOC) (MK-7339-001/KEYLYNK-001/ENGOT-ov43/GOG-3036)

Study of Subcutaneous (SC) Belimumab in Pediatric Participants With Systemic Lupus Erythematosus (SLE)

CAMP RWE Trial: Amnion Grafts for Healing Hard-to-Heal Ulcers in RW Populations

A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder

Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants With SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)

Azacitidine Combined With Pembrolizumab and Epacadostat in Subjects With Advanced Solid Tumors (ECHO-206)

Real-World Patient Experiences Using Continuous Subcutaneous Apomorphine Infusion (ONAPGOTM) in the United States:

A Study of LY3127804 With Ramucirumab in Participants With Advanced Solid Tumors

Multidisciplinary Translational Approach to Investigate Mechanisms Predictors & Prevention of Persistent PTH